Press Releases - 2023-07-03

Date	Title	Company
03-Jul-2023	Anticipated Expansion of Pharmacy Refrigerators Market \| Expected Valuation of US$ 1.03 Billion by 2032 with a CAGR of 5.8%	MARKITWIRED
03-Jul-2023	Smart Pill Boxes and Bottles Market is anticipated to reach US$ 388.2 Million by 2033, at a CAGR of 9.3%	MARKITWIRED
03-Jul-2023	Upper Limb Prosthetics Market Revenue is anticipated to reach US$ 624.9 million by 2033	MARKITWIRED
03-Jul-2023	Retail Clinics Market is projected to reach US$ 8.05 Billion by the end of 2028, at a CAGR of 9.6%	MARKITWIRED
03-Jul-2023	Vision Screeners Market is anticipated to reach US$ 815.2 Million by 2029, with a CAGR of 5.9%	MARKITWIRED
03-Jul-2023	Absorbable Tissue Spacer Market is predicted to advance at a CAGR of 10% from 2022 to 2032	MARKITWIRED
03-Jul-2023	Tissue Engineered Skin Substitute Market is expected to reach US$ 4.13 Billion by 2029, with CAGR of 9.6%	MARKITWIRED
03-Jul-2023	Radiation Toxicity Treatment Market is anticipated to reach US$ 5.58 Billion by 2029, with a CAGR of 5.8%	MARKITWIRED
03-Jul-2023	IV Poles Market Share 2022 to 2029 \| By Medline, Centicare, AliMed, 3M Healthcare, A.M.G. Medical	MARKITWIRED
03-Jul-2023	Nucleic Acid and Gene Therapies in Neuromuscular Disorders Market is projected to grow at a CAGR of 9.5% totaling around US$ 19.52 Billion by 2033	MARKITWIRED
03-Jul-2023	Advanced Therapy Medicinal Products Market \| Bluebird Bio, Inc., Novartis AG, UniQure N.V., Celgene Corporation \| By 2032	MARKITWIRED
03-Jul-2023	Age Related Vision Dysfunction Industry Worth to reach US$ 130 Billion by 2033; growing at a 3.7% CAGR in the Forthcoming Decade: FMI	MARKITWIRED
03-Jul-2023	Mesotherapy Market is projected to increase at a CAGR of around 17.5% from 2022 to 2032	MARKITWIRED
03-Jul-2023	Vernal Keratoconjunctivitis Market is expected to accumulate a value of US$ 782.42 Million by registering a CAGR of 6%	MARKITWIRED
03-Jul-2023	Biopsy Guidance System Market is projected to reach US$ 2 Billion by 2032 at a CAGR of 5.8%	MARKITWIRED
03-Jul-2023	Celltrion USA Launches Yuflyma® (adalimumab-aaty), a Humira® (adalimumab) biosimilar, in the United States	Businesswire
03-Jul-2023	Rare NGR1 Fusion Market is likely to reach US$ 20 Billion by 2033, with a CAGR of 7.73%	MARKITWIRED
03-Jul-2023	Primary Sclerosing Cholangitis (PSC) Market is projected to grow at a CAGR of 7.6%, totaling around US$ 314.26 Million by 2033	MARKITWIRED
03-Jul-2023	Amyotrophic Lateral Sclerosis is expected to accumulate a market value of US$ 1332.22 Million by registering a CAGR of 6% 2023 to 2033	MARKITWIRED
03-Jul-2023	Drug-Induced Dyskinesia Market is expected to grow at a steady 4.25% CAGR, reaching a value of US$ 620.2 Million by 2033	MARKITWIRED